0 Comentários
0 Compartilhamentos
332 Visualizações
0 Anterior
Pesquisar
Conheça novas pessoas, crie conexões e faça novos amigos
-
Faça o login para curtir, compartilhar e comentar!
-
Hemato Oncology Testing Market Size, Precision Medicine Trends, and Strategic Industry Outlook 2032"Latest Insights on Executive Summary Hemato Oncology Testing Market Share and Size During the forecast period of 2025 to 2032 the market is likely to grow at a CAGR of 7.80% , primarily driven by the rising incidence of blood cancers This Hemato Oncology Testing Market research report proves to be true in serving the purpose of businesses of making enhanced decisions,...0 Comentários 0 Compartilhamentos 610 Visualizações 0 Anterior
-
Hereditary Cancer Testing Market Size and Precision Oncology Trends 2033The growing emphasis on personalized medicine and proactive risk management is driving a significant expansion in genomic screening. The Hereditary Cancer Testing Market was valued at USD 7.04 billion in 2024 and is projected to reach USD 18.85 billion by 2032, growing at a CAGR of 20.87% during the forecast period of 2025 to 2032. This growth is fueled by the...0 Comentários 0 Compartilhamentos 267 Visualizações 0 Anterior
-
Kidney Cancer Diagnostics Market – Precision Oncology Tools, Early Detection Technologies & Clinical Accuracy"Executive Summary Kidney Cancer Diagnostics Market: Growth Trends and Share Breakdown CAGR Value Data Bridge Market Research analyzes that the kidney cancer diagnostics market is expected to reach a value of USD 16,862.32 million by 2030, at a CAGR of 6.4% during the forecast period. The key highlights of this Kidney Cancer Diagnostics Market report are key market dynamics, the current...0 Comentários 0 Compartilhamentos 657 Visualizações 0 Anterior
-
Merkel Cell Carcinoma Treatment Market: Immune Checkpoint Inhibitor (ICI) Advancements, Combination Therapy Pipelines, and Precision Oncology Strategies"Latest Insights on Executive Summary Merkel Cell Carcinoma Treatment Market Share and Size Data Bridge Market Research analyses a growth rate in the merkel cell carcinoma treatment market in the forecast period 2022-2029. The expected CAGR of merkel cell carcinoma treatment market is tend to be around 3.87% in the mentioned forecast period. The market was valued at USD 3.24 billion in 2021,...0 Comentários 0 Compartilhamentos 754 Visualizações 0 Anterior
-
Myxoid Round Cell Liposarcoma (MRCLS) Drug Market – Precision Oncology Therapies, Rare Cancer Research & Clinical Pipeline"Global Executive Summary Myxoid Round Cell Liposarcoma (MRCLS) Drug Market: Size, Share, and Forecast CAGR Value The Global Myxoid Round Cell Liposarcoma (MRCLS) Drug Market size was valued at USD 10.61 billion in 2024 and is expected to reach USD 14.3 billion by 2032, at a CAGR of 3.81% during the forecast period While preparing the first class Myxoid Round Cell Liposarcoma (MRCLS) Drug...0 Comentários 0 Compartilhamentos 455 Visualizações 0 Anterior
-
Precision Oncology and Technological Advancements Driving Radiopharmaceutical Therapeutic Market at 13.1% CAGRRadiopharmaceutical therapeutics refer to pharmaceutical compounds containing radioactive isotopes that are used for treating cancer and other medical conditions. These compounds are specifically designed to target disease sites and deliver precise doses of radiation, minimizing damage to surrounding healthy tissues. The integration of radiopharmaceutical therapeutics with advanced imaging and...0 Comentários 0 Compartilhamentos 571 Visualizações 0 Anterior
-
Precision Oncology Market Dynamics: Opportunities, Challenges, and Emerging Trends 2030Global Precision Oncology Market Outlook: Personalized Cancer Care Driving a USD 190 Billion Opportunity by 2030 The global Precision Oncology Market is undergoing a transformational phase as cancer treatment shifts from conventional protocols toward personalized, molecularly guided therapies. Valued at USD 98.36 billion in 2023, the market is projected to expand at...0 Comentários 0 Compartilhamentos 516 Visualizações 0 Anterior
-
Salivary Gland Cancer Treatment Market: Targeted Therapy Pipeline, Precision Oncology Strategies"Executive Summary Salivary Gland Cancer Treatment Market Size and Share Analysis Report The global salivary gland cancer treatment market size was valued at USD 1.78 billion in 2024 and is expected to reach USD 3.27 billion by 2032, at a CAGR of 7.90% during the forecast period The global Salivary Gland Cancer Treatment Market research report has incorporated...0 Comentários 0 Compartilhamentos 789 Visualizações 0 Anterior
-
The Biological Rationale for Next-Generation Sequencing and Precision Oncology within the France Contract Research Organization Sector for 2025The demand for specialized oncology trials in France has surged in late 2025, driven by the integration of Next-Generation Sequencing (NGS) into standard clinical research protocols. Contract research entities are increasingly tasked with managing "basket" and "umbrella" trials that group patients based on molecular biomarkers rather than traditional tumor locations. This shift requires a high...0 Comentários 0 Compartilhamentos 673 Visualizações 0 Anterior
-
Topoisomerase Inhibitors Market Advancing Precision Oncology TherapiesExecutive Summary Topoisomerase Inhibitors Market Size and Share Forecast CAGR Value Data Bridge Market Research analyses that the topoisomerase inhibitors will exhibit a CAGR of around 5.10% for the forecast period of 2022-202 This Topoisomerase Inhibitors Market Research Report also conducts analysis on consumption of the market, key players involved, sales, price, revenue, and...0 Comentários 0 Compartilhamentos 719 Visualizações 0 Anterior
-
Trastuzumab Emtansine Market: A Precision Oncology Game-Changer on the RiseThe global trastuzumab emtansine market size was valued at USD 2.47 billion in 2024 and is expected to reach USD 4.78 billion by 2032, at a CAGR of 8.62% during the forecast period This market analysis delves into growing demand, regulatory shifts, emerging indications, and competitive dynamics in the trastuzumab emtansine landscape. Introduction Trastuzumab...0 Comentários 0 Compartilhamentos 1KB Visualizações 0 Anterior
-
Brigatinib API Market Growing at 8.1% CAGR Through 2034 GloballyAccording to a new report from Intel Market Research, the global Brigatinib API market was valued at USD 42.5 million in 2025 and is projected to reach USD 89.7 million by 2034, growing at a robust CAGR of 8.1% during the forecast period (2026–2034). This growth is propelled by the increasing global incidence of non-small cell lung cancer, particularly ALK-positive cases among...0 Comentários 0 Compartilhamentos 114 Visualizações 0 Anterior
-
Cancer/Tumor Profiling Market Size Projected to Reach USD 23.4 Billion by 2032“According to a new report published by Introspective Market Research, Cancer/Tumor Profiling Market by Technology, Cancer Type, and Application, The Global Cancer/Tumor Profiling Market Size Was Valued at USD 11.08 Billion in 2024 and is Projected to Reach USD 23.4 Billion by 2032, Growing at a CAGR of 9.8%.” Cancer/Tumor Profiling refers to the comprehensive molecular examination...0 Comentários 0 Compartilhamentos 733 Visualizações 0 Anterior
-
Global Cabozantinib Drug Market Growing at 7.5% CAGR Through 2034According to a new report from Intel Market Research, the global Cabozantinib Drug market was valued at USD 2.12 billion in 2025 and is projected to reach USD 4.01 billion by 2034, growing at a robust CAGR of 7.5% during the forecast period (2026–2034). This growth is propelled by the escalating global burden of cancer, particularly renal and liver cancers, alongside expanding clinical...0 Comentários 0 Compartilhamentos 80 Visualizações 0 Anterior
-
Global Multi-target MET TKIs Market Growing at 7.6% CAGR Through 2034According to a new report from Intel Market Research, the global Multi-target MET TKIs market was valued at USD 1.52 billion in 2025 and is projected to reach USD 3.18 billion by 2034, growing at a CAGR of 7.6% during the forecast period (2026–2034). This growth is propelled by the rising global incidence of non-small cell lung cancer and medullary thyroid cancer, precision oncology...0 Comentários 0 Compartilhamentos 65 Visualizações 0 Anterior
Páginas impulsionada
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Greek